Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biontech Se ADR
(NQ:
BNTX
)
88.22
+0.62 (+0.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biontech Se ADR
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
63
64
Next >
White House Says Currently No Plans To Share COVID-19 Shots With North Korea Battling Outbreak
May 13, 2022
The Biden administration says it currently has no plans to share COVID-19 vaccines with North Korea, Reuters reported citing White House press secretary Jen Psaki. However, it supported providing aid...
Via
Benzinga
Stock Market Tries To Bounce From Fresh 2022 Lows; Tesla CEO Elon Musk Puts Twitter Deal 'On Hold': Weekly Review
May 13, 2022
Elon Musk put his Twitter deal "on hold" but says he's "still committed" to it.
Via
Investor's Business Daily
Cboe's Weekly Market Recap: May 2nd To May 6th
May 11, 2022
Photo by m. on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Where BioNTech Stands With Analysts
May 10, 2022
Within the last quarter, BioNTech (NASDAQ:BNTX) has observed the following analyst ratings:
Via
Benzinga
Why BioNTech Stock Is Rising Today
May 09, 2022
BioNTech SE (NASDAQ: BNTX) shares are trading higher Monday after the company reported financial results and reaffirmed its 2022 outlook.
Via
Benzinga
BioNTech Clocks Over $6B In Q1 Sales, Sticks To FY22 Guidance
May 09, 2022
Via
Benzinga
Should Biotech Be On The Critical List?
May 11, 2022
The risk-off market has played havoc with the biotechs where the fundamentals have not changed as much as the valuation.
Via
Talk Markets
Novavax's 22% Post-Earnings Plunge: 5 Factors That Took Toll
May 10, 2022
Novavax, Inc. (NASDAQ: NVAX) shares slumped 22.27% after-hours on Monday, reacting to its quarterly financial report.
Via
Benzinga
BNTX Stock Treks Higher on BioNTech’s Vaccine Sales
May 09, 2022
BNTX stock is climbing on Monday after BioNTech reported better-than-expected results. The company credits Covid-19 vaccine innovation.
Via
InvestorPlace
Cash Appears To Be King As Investors Sell Stocks, Bonds, And Commodities
May 09, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Recap: BioNTech Q1 Earnings
May 09, 2022
BioNTech (NASDAQ:BNTX) reported its Q1 earnings results on Monday, May 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings BioNTech reported an EPS of $15.97.
Via
Benzinga
BioNTech's Revenue Triples On Omicron Demand For Its Pfizer-Partnered Covid Shot
May 09, 2022
BioNTech beat first-quarter sales expectations by more than $2 billion.
Via
Investor's Business Daily
Palantir, Plug Power, Novavax, BioNTech, Lordstown: 5 Key Earnings To Watch Today
May 09, 2022
The first-quarter reporting season is well and truly underway.
Via
Benzinga
5 Stocks To Watch For May 9, 2022
May 09, 2022
Some of the stocks that may grab investor focus today are:
Via
Benzinga
Bulls Look To Bounce Back After Bear Barrage
May 06, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
S&P 500 and Dow Lose 3% While Nasdaq Composite Slides 5%
May 06, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
FDA Limits Use of Johnson & Johnson's COVID-19 Vaccine to Certain Individuals - All You Should Know
May 06, 2022
The FDA said it was limiting the use of Johnson & Johnson's (NYSE:
Via
Benzinga
7 Dividend-Paying Large-Cap Stocks to Buy in May
May 06, 2022
These dividend-paying large-cap stocks offer an attractive buffer against the current macro-economic climate.
Via
InvestorPlace
Arcturus Reports Three-Month Durability Results From ARCT-154 COVID-19 Booster Trial
May 05, 2022
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) provided updated data from its Phase 1/2 booster clinical trial showing the durability of antibody response with ARCT-154 for at least three months...
Via
Benzinga
Textbook Company's Results Show Students Are Hitting The Job Market Instead Of The Books
May 05, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
US Study Shows Omicron As Severe As Previous COVID Variants: Reuters
May 05, 2022
Via
Benzinga
Pfizer: The Treasure of Albert Bourla
May 04, 2022
Pfizer won the lottery with Covid-19, but how it invests that cash will determine how well the stock does in the longer-term.
Via
InvestorPlace
Lyft And Uber Battle Over Earnings Ahead Of The Fed Announcement
May 04, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Bulls Try To Build On Yesterday's Gains But Looming Fed Decision Could Curb Trading
May 03, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Moderna Bullish On COVID-19 Vaccine For Younger Kids To Be Ready Next Month: Reuters
May 02, 2022
Via
Benzinga
April's Sell-Off Continues Into May As Futures Point To A Lower Open
May 02, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Disappointing Earnings And A Spike In Inflation Send Stocks Plunging
May 02, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, May 2
May 02, 2022
CNBC Fourth COVID-19 Shot? See Why Medical Professionals Are Skeptical Medical professionals are undecided on whether a fourth dose of the Covid-19 vaccine would benefit the...
Via
Benzinga
Fourth COVID-19 Shot? See Why Medical Professionals Are Skeptical
May 02, 2022
Medical professionals are undecided on whether a fourth dose of the Covid-19 vaccine would benefit the wider population, as countries are beginning to offer the fourth dose to vulnerable groups.
Via
Benzinga
FDA Sets Review Dates For Pfizer, Moderna COVID-19 Shot For Kids, Plus Novavax EUA
April 29, 2022
Via
Benzinga
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
63
64
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.